Berentzen-Gruppe Aktiengesellschaft

  • WKN: 520160
  • ISIN: DE0005201602
  • Land: Deutschland

Nachricht vom 03.01.2017 | 19:05

Berentzen-Gruppe Aktiengesellschaft: CEO Frank Schübel will not renew his term of office - he is willing to serve on the Supervisory Board

DGAP-News: Berentzen-Gruppe Aktiengesellschaft / Key word(s): Change of Personnel

03.01.2017 / 19:05
The issuer is solely responsible for the content of this announcement.



P R E S S R E L E A S E No. 1/2017

Released for immediate publication

Berentzen Group: CEO Frank Schübel will not renew his term of office - he is willing to serve on the Supervisory Board

Haselünne, 3 January 2017 - Frank Schübel, CEO of Berentzen-Gruppe Aktiengesellschaft, informed the company's Supervisory Board Chairman on today's date that he will not renew his term of office, which ends on 30 October 2017.

"After being more than four years CEO of Berentzen-Gruppe Aktiengesellschaft, I have decided to make a change for personal reasons," Frank Schübel explained. "I am handing over responsibility for the Group at a time when it is very well positioned both strategically and organizationally. Important measures to be taken in fiscal year 2017, such as price increases, the launch of new innovations and technical improvements, are already being successfully implemented and will further support the Group's positive performance," the CEO said.

Schübel is willing to continue serving the Group as a member of the Supervisory Board of Berentzen-Gruppe Aktiengesellschaft, in order to ensure strategic continuity and expertise, among other things: "To send a clear signal that our successful management strategy will be continued, I will gladly stand for election to the Supervisory Board, if this is the wish of the shareholders. I think this is the right time to make this proposal, while giving a new Executive Board member the chance to generate fresh momentum."

Supervisory Board Chairman Gert Purkert: "We always had a very trustful working relationship with Mr. Schübel and would like to thank him already now for his outstanding work in the service of the Berentzen Group. And yet, we understand his wish for a personal change. If a seat becomes vacant on the Supervisory Board and if the shareholders propose him for election, we will support his candidacy within the scope of our possibilities."

Frank Schübel has served on the Executive Board of Berentzen-Gruppe Aktiengesellschaft since November 2012 and has been CEO since January 2013. He leads the Berentzen Group together with CFO Ralf Brühöfner.


About the Berentzen Group:
The Berentzen Group is a broad-based beverage company operating in the following three segments: Spirits, Non-alcoholic Beverages and Fresh Juice Systems. The Berentzen Group is one of the oldest producers of spirits in Germany with a corporate history going back over 250 years. Today, it has a presence in more than 60 countries around the world with well-known brands like Berentzen and Puschkin and attractively priced private label products. In its Non-alcoholic Beverages segment, the corporate group produces mineral waters, carbonated and non-carbonated soft drinks under its own brands and also boasts more than 50 years of experience in the franchise business for soft drinks, currently acting as franchisee for the Sinalco brand. In addition, the Berentzen Group markets innovative fresh juice systems under the Citrocasa brand in its third segment, thus serving the fast-growing market for modern, health-oriented drinks. The Berentzen-Gruppe Aktiengesellschaft share (ISIN DE0005201602) is listed on the regulated market (General Standard) of the Frankfurt Stock Exchange.

For more information
www.berentzen-gruppe.de

Berentzen-Gruppe Aktiengesellschaft
Antje Schwindeler
Press and PR
Tel. +49 (0)5961-502215
pr@berentzen.de



03.01.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

Ergomed PLC: Kursziel angehoben

Die erfolgreiche Wirksamkeitsstudie von Lorediplon zeigt, dass Ergomed PLC eine sehr vielversprechende Co-Development-Pipeline hat. Eine mögliche vorzeitige Auslizenzierungen des Produkts würde dem Unternehmen signifikante Erfolgsbeteiligungen sichern. Deshalb und aufgrund der Anpassung der Wechselkurse erhöhen wir den fairen Wert der Ergomed-Aktie auf 3,41 € je Aktie. Das Rating bleibt KAUFEN.

Aktueller Webcast

Elmos Semiconductor AG

Analysts' Conference Call FY 2016

15. Februar 2017

Aktuelle Research-Studie

Ergomed plc

Original-Research: Ergomed plc (von GBC AG): Kaufen

21. Februar 2017